At a glance
A naturally occurring tripeptide central to cellular redox chemistry.
This profile separates the compound’s scientific background from specification-specific preparation and source schedules. Begin with the research findings and limitations, then select the formulation you want to examine.
How it works
Potential benefits & side effects
Interpret each outcome in the context of the study population, formulation and evidence type. Research findings do not establish a personal treatment outcome.
Potential benefits & research findings
The source discusses oxidative-stress and other clinical markers. Normal antioxidant biology alone does not prove that a particular administration method improves health.[1][10][9]
Read the original publications to see the measured endpoints, comparator, duration and uncertainty. Mechanistic plausibility and a favorable experimental result are different from demonstrated clinical benefit.
Side effects & evidence limitations
Interpret the reported adverse effects together with the study population, route and observation period. Small or short studies can miss uncommon and delayed harms. Evidence from a related compound does not establish the safety of Glutathione.
Source-reported adverse effects and cautions
Sources are available for independent reading. Individual claims and research schedules have not yet undergone an independent clinical review by Pep Science.
- Editorial responsibility
- Pep Science editorial desk
- Last independent review
- Not yet recorded
SPECIFICATIONS & SOURCE SCHEDULES
Explore a vial size
Select the exact formulation. Vial content, target dose and prepared concentration are different measurements.
Showing 600 mg · 1 source tables
Standard / Gradual Approach (2 mL = 300 mg/mL)
| Week | Daily Dose (mg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 100 mg | 33 units (0.33 mL) |
| Weeks 3–4 | 150 mg | 50 units (0.50 mL) |
| Weeks 5–8 | 200 mg | 67 units (0.67 mL) |
Frequency: Inject once daily subcutaneously, or split into every-other-day dosing based on protocol goals[5]. Some protocols utilize 200 mg 1–2 × weekly for maintenance[6]. This schedule uses a practical 2.0 mL dilution for accurate measurements with standard insulin syringes.
Additional schedule context & duration
Concise summary of the subcutaneous regimen.
- Goal: Support antioxidant defense, cellular detoxification, and immune function[1][3].
- Schedule: Daily or every-other-day subcutaneous injections for 4–8 weeks.
- Dose Range: 100–200 mg daily with gradual titration.
- Reconstitution: 2.0 mL per 600 mg vial (300 mg/mL) for accurate unit measurements.
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Suggested daily titration approach.
- Start: 100 mg daily; increase by ~50 mg every 1–2 weeks as tolerated.
- Target: 150–200 mg daily by Weeks 3–8.
- Frequency: Once per day (subcutaneous) or every other day for maintenance.
- Cycle Length: 4–8 weeks; optional cycling off for 2–4 weeks between protocols.
- Timing: Any consistent time; rotate injection sites.
Read this protocol on Pep Science → · View cited documents ↓
Preparation
Reconstitution Steps
- Draw 2.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Storage Instructions
Proper storage preserves peptide quality.
- Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
- Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use promptly and avoid freeze–thaw.
- Allow vials to reach room temperature before opening to reduce condensation uptake.
- Glutathione is relatively unstable once reconstituted—use within 2–3 weeks for optimal potency[6].
Injection Technique
General subcutaneous guidance from clinical best-practice resources[16].
- Clean the vial stopper and skin with alcohol; allow to dry.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[17][18].
- Do not aspirate for subcutaneous injections; inject slowly and steadily[17].
- Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[19].
Materials & quantity planning
Source materials checklist · 600 mg
Plan based on a 4–8 week daily protocol with gradual titration.
-
Peptide Vials (Glutathione, 600 mg each):
- 4 weeks (100–150 mg/day avg) ≈ 3 vials
- 8 weeks (150–200 mg/day avg) ≈ 7 vials
-
Insulin Syringes (U-100):
- Per week: 7 syringes (1/day)
- 4 weeks: 28 syringes
- 8 weeks: 56 syringes
-
Bacteriostatic Water (10 mL bottles): Use ~2.0 mL per vial for reconstitution.
- 4 weeks (3 vials): 6 mL → 1 × 10 mL bottle
- 8 weeks (7 vials): 14 mL → 2 × 10 mL bottles
-
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 4 weeks: 56 swabs → recommend 1 × 100-count box
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
Calculate a phased quantity
Enter each finite phase from the schedule you are studying. Open-ended phases need an explicit duration. Calculation uses 600 mg per vial and 2 mL per vial.
Complete each phase to calculate totals.
Quantity estimates exclude preparation losses and expiry. Follow the formulation’s handling and disposal requirements.
FOLLOW THE EVIDENCE
References & further reading
Original publications and source documents cited across this product’s variants. A listed source is not an independent endorsement of a dosing schedule.
- 01
Research publication
PubMed — The antioxidant glutathione: protective roles, cofactor functions, and regeneration mechanisms (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 02
Research publication
PubMed — Glutathione and glutathione-dependent enzymes: coordinated defense against oxidative stress (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 03
Public health resource
PMC — Glutathione: roles in immune function, detoxification, and clinical applications (opens in a new tab)www.ncbi.nlm.nih.gov
Back to overview ↑ - 04
Research publication
PubMed — The interplay of glutathione-related processes in antioxidant defense (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 05
Research publication
PMC — Exploring safety and efficacy of glutathione supplementation: narrative review (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 06
Research publication
PubMed — Glutathione as a skin-lightening agent and in melasma: systematic review (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 07
Research publication
PMC — Glutathione: pharmacological aspects and implications for clinical use in NAFLD (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 08
Research publication
PubMed — Oxidative stress: role of mitochondria and protection by glutathione (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 09
Research publication
PMC — Efficacy of glutathione for NAFLD treatment: open-label pilot study (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 10
Research publication
PMC — Protective effect of glutathione against oxidative stress-induced cytotoxicity via Nrf2/HO-1 pathway (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 11
Research publication
PubMed — Glutathione in the treatment of liver diseases: clinical practice insights (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 13
Research publication
PubMed — Clinical effect of glutathione on skin color and related conditions: systematic review (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 14
Research publication
PMC — Glutathione and its antiaging and antimelanogenic effects: RCT at 250 mg/day (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 15
Research publication
PubMed — Oxidative stress and regulation of glutathione in lung inflammation (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 16
Research publication
PMC — Subcutaneous drug injection review: pharmacologic considerations (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 17
Public health resource
CDC — Vaccine administration: subcutaneous route (angle/site; no aspiration) (opens in a new tab)www.cdc.gov
Back to overview ↑ - 18
Public health resource
CDC (Subcut Injection PDF) — Technique diagram and site guidance for subcutaneous injections (opens in a new tab)www.cdc.gov
Back to overview ↑ - 19
Public health resource
NCBI Bookshelf — Best practices for injection (asepsis, preparation, and administration) (opens in a new tab)www.ncbi.nlm.nih.gov
Back to overview ↑
Continue exploring
Related topics are not interchangeable compounds or formulations.